John Wm Martens

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, GE, The Netherlands
    Breast Cancer Res 12:R103. 2010
  2. pmc Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
    Jack X Yu
    Veridex LLC, a Johnson and Johnson Company, 3210 Merryfield Row, San Diego, CA 92121, USA
    BMC Cancer 7:182. 2007
  3. pmc CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients
    Dimo Dietrich
    Epigenomics AG, Berlin, Germany
    BMC Cancer 10:247. 2010

Detail Information

Publications3

  1. pmc Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
    Anieta M Sieuwerts
    Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, GE, The Netherlands
    Breast Cancer Res 12:R103. 2010
    ....
  2. pmc Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
    Jack X Yu
    Veridex LLC, a Johnson and Johnson Company, 3210 Merryfield Row, San Diego, CA 92121, USA
    BMC Cancer 7:182. 2007
    ..Published prognostic gene signatures in breast cancer have few genes in common. Here we provide a rationale for this observation by studying the prognostic power and the underlying biological pathways of different gene signatures...
  3. pmc CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients
    Dimo Dietrich
    Epigenomics AG, Berlin, Germany
    BMC Cancer 10:247. 2010
    ..In this study, the DNA methylation status of 202 candidate loci was screened to identify those loci that may predict outcome in LNP/estrogen receptor-positive (ER+) breast cancer patients with adjuvant anthracycline-based chemotherapy...